Sodium–glucose co-transporter 2 inhibitors as an early, first-line therapy in patients with heart failure and reduced ejection fraction

by Adamo, M., Anker, S.D, Butler, J., Coats, A.J.S, Filippatos, G., Fonarow, G.C, Greene, S.J, McDonagh, T.A, Metra, M., Ponikowski, P., Rosano, G., Seferovic, P., Tomasoni, D., Vaduganathan, M., Voors, A.A
Published 2022